These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 11600499)
1. Mimetics of a T cell epitope based on poly-N-acylated amine backbone structures induce T cells in vitro and in vivo. Hin S; Bianco A; Zabel C; Jung G; Walden P J Biol Chem; 2001 Dec; 276(52):48790-6. PubMed ID: 11600499 [TBL] [Abstract][Full Text] [Related]
2. Identification and Structure of an MHC Class I-Encoded Protein with the Potential to Present Yamamoto Y; Morita D; Shima Y; Midorikawa A; Mizutani T; Suzuki J; Mori N; Shiina T; Inoko H; Tanaka Y; Mikami B; Sugita M J Immunol; 2019 Jun; 202(12):3349-3358. PubMed ID: 31043477 [TBL] [Abstract][Full Text] [Related]
3. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses. Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072 [TBL] [Abstract][Full Text] [Related]
4. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594 [TBL] [Abstract][Full Text] [Related]
5. Three different MHC class I molecules bind the same CTL epitope of the influenza virus in a primate species with limited MHC class I diversity. Evans DT; Knapp LA; Jing P; Piekarczyk MS; Hinshaw VS; Watkins DI J Immunol; 1999 Apr; 162(7):3970-7. PubMed ID: 10201917 [TBL] [Abstract][Full Text] [Related]
6. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation. Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164 [TBL] [Abstract][Full Text] [Related]
7. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I. Chen ZW; Craiu A; Shen L; Kuroda MJ; Iroku UC; Watkins DI; Voss G; Letvin NL J Immunol; 2000 Jun; 164(12):6474-9. PubMed ID: 10843704 [TBL] [Abstract][Full Text] [Related]
8. The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires. Bergmann T; Moore C; Sidney J; Miller D; Tallmadge R; Harman RM; Oseroff C; Wriston A; Shabanowitz J; Hunt DF; Osterrieder N; Peters B; Antczak DF; Sette A Immunogenetics; 2015 Nov; 67(11-12):675-89. PubMed ID: 26399241 [TBL] [Abstract][Full Text] [Related]
9. New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules. Bianco A; Brock C; Zabel C; Walk T; Walden P; Jung G J Biol Chem; 1998 Oct; 273(44):28759-65. PubMed ID: 9786873 [TBL] [Abstract][Full Text] [Related]
10. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule. McGuire TC; Leib SR; Mealey RH; Fraser DG; Prieur DJ J Immunol; 2003 Aug; 171(4):1984-93. PubMed ID: 12902502 [TBL] [Abstract][Full Text] [Related]
11. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells. Hardy LL; Wick DA; Webb JR J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715 [TBL] [Abstract][Full Text] [Related]
12. Interaction profiling of T-cell epitopes with MHC-class I molecules. Dash BP; Mukherjee S; Suhas VL; Chandra N Protein Pept Lett; 2007; 14(6):557-64. PubMed ID: 17627596 [TBL] [Abstract][Full Text] [Related]
13. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis. Fonseca DP; Joosten D; Snippe H; Verheul AF Mol Immunol; 2000 Jun; 37(8):413-22. PubMed ID: 11090876 [TBL] [Abstract][Full Text] [Related]
15. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521 [TBL] [Abstract][Full Text] [Related]
16. Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope. Vierboom MP; Feltkamp MC; Neisig A; Drijfhout JW; ter Schegget J; Neefjes JJ; Melief CJ; Kast WM J Immunother; 1998 Nov; 21(6):399-408. PubMed ID: 9807734 [TBL] [Abstract][Full Text] [Related]
18. A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL. Mealey RH; Lee JH; Leib SR; Littke MH; McGuire TC J Immunol; 2006 Nov; 177(10):7377-90. PubMed ID: 17082657 [TBL] [Abstract][Full Text] [Related]
19. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides. Sauzet JP; Gras-Masse H; Guillet JG; Gomard E Int Immunol; 1996 Apr; 8(4):457-65. PubMed ID: 8671632 [TBL] [Abstract][Full Text] [Related]